Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Shareholders' Deficit (Unaudited)

v3.24.0.1
Condensed Consolidated Statement of Changes in Shareholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock To Be Issued [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance at Mar. 31, 2022 $ 500 $ 67,500 $ 96,701,607 $ 20,132,650 $ (150,036,023) $ (33,133,765)
Balance, shares at Mar. 31, 2022 5,000,000 674,644,124          
Common stock issued for legal settlement to NSH shareholders $ 6,112 19,311,486 (19,317,598)
Common stock issued for legal settlement to NSH shareholders, shares   61,154,136          
Conversion of Series E Preferred Shares to common stock $ 454 839,546 840,000
Conversion of Series E Preferred Shares to common stock, shares   4,537,240          
Dividends payable on Preferred Shares (102,227) (102,227)
Net income (loss) (2,200,176) (2,200,176)
Accretion of Series E Preferred Shares (278,500) (278,500)
Contingent beneficial conversion feature related to the Series E Preferred Shares, fully amortized 99,000 (99,000)
Amortization of beneficial conversion feature related to Series E Preferred Shares (42,500) (42,500)
Common stock issued in business agreement, to be paid from revenue earned $ 25 56,225 (56,250)
Common stock issued in business agreement, to be paid from revenue earned, shares   250,000          
Common stock vested to consultants $ 6 24,369 24,375
Balance at Jun. 30, 2022 $ 500 $ 74,097 117,032,233 815,052 (56,250) (152,758,426) (34,892,793)
Balance, shares at Jun. 30, 2022 5,000,000 740,585,500          
Balance at Mar. 31, 2022 $ 500 $ 67,500 96,701,607 20,132,650 (150,036,023) (33,133,765)
Balance, shares at Mar. 31, 2022 5,000,000 674,644,124          
Net income (loss)             (11,552,820)
Balance at Dec. 31, 2022 $ 500 $ 76,894 119,464,471 662,767 (56,250) (163,037,985) (42,889,603)
Balance, shares at Dec. 31, 2022 5,000,000 768,561,129          
Balance at Jun. 30, 2022 $ 500 $ 74,097 117,032,233 815,052 (56,250) (152,758,426) (34,892,793)
Balance, shares at Jun. 30, 2022 5,000,000 740,585,500          
Common stock issued for legal settlement to NSH shareholders $ 40 127,646 (127,686)
Common stock issued for legal settlement to NSH shareholders, shares   404,067          
Conversion of Series E Preferred Shares to common stock $ 992 827,008 (108,000) 720,000
Conversion of Series E Preferred Shares to common stock, shares   9,920,887          
Dividends payable on Preferred Shares (55,427) (55,427)
Net income (loss) (24,528,345) (24,528,345)
Accretion of Series E Preferred Shares (278,500) (278,500)
Amortization of beneficial conversion feature related to Series E Preferred Shares (42,500) (42,500)
Common stock vested to consultants 6 24,369 24,375
Increase of 10% in Series E Preferred Shares to one holder based on certain rights (156,000) (156,000)
Common stock issued in business agreement $ 25 25,975 26,000
Common stock issued in business agreement, shares   250,000          
Common stock issued from shares payable $ 10 24,590 (24,600)
Common stock issued from shares payable, shares   100,000          
Common stock vested to consultants, shares   62,500          
Balance at Sep. 30, 2022 $ 500 $ 75,170 118,061,820 662,767 (56,250) (177,927,198) (59,183,191)
Balance, shares at Sep. 30, 2022 5,000,000 751,322,954          
Issuance of common shares under financing agreement   $ 1,718 1,378,282       1,380,000
Issuance of common shares under financing agreement, shares   17,175,675          
Dividends payable on Preferred Shares (60,107) (60,107)
Net income (loss) 15,175,701 15,175,701
Accretion of Series E Preferred Shares (198,333) (198,333)
Amortization of beneficial conversion feature related to Series E Preferred Shares (28,048) (28,048)
Common stock vested to consultants $ 6 24,369 24,375
Common stock vested to consultants, shares   62,500          
Balance at Dec. 31, 2022 $ 500 $ 76,894 119,464,471 662,767 (56,250) (163,037,985) (42,889,603)
Balance, shares at Dec. 31, 2022 5,000,000 768,561,129          
Balance at Mar. 31, 2023 $ 500 $ 80,377 121,156,733 662,767 (56,250) (167,533,292) (45,689,165)
Balance, shares at Mar. 31, 2023 5,000,000 803,123,748          
Common stock issued for legal settlement to NSH shareholders $ 86 272,657 (272,743)
Common stock issued for legal settlement to NSH shareholders, shares   863,110          
Issuance of common shares under financing agreement $ 4,019 1,294,493 1,298,512
Issuance of common shares under financing agreement, shares   40,187,311          
Conversion of Series E Preferred Shares to common stock $ 2,399 825,601 (350,825) 477,175
Conversion of Series E Preferred Shares to common stock, shares   23,989,570          
Dividends payable on Preferred Shares (54,000) (54,000)
Common stock issued to consultants $ 10 4,690 4,700
Common stock issued to consultants, shares   100,000          
Net income (loss) (2,298,431) (2,298,431)
Balance at Jun. 30, 2023 $ 500 $ 86,891 123,554,174 390,024 (56,250) (170,236,548) (46,261,209)
Balance, shares at Jun. 30, 2023 5,000,000 868,263,739          
Balance at Mar. 31, 2023 $ 500 $ 80,377 121,156,733 662,767 (56,250) (167,533,292) (45,689,165)
Balance, shares at Mar. 31, 2023 5,000,000 803,123,748          
Net income (loss)             (10,347,034)
Balance at Dec. 31, 2023 $ 500 $ 99,560 125,327,383 390,024 (56,250) (178,425,983) (52,664,766)
Balance, shares at Dec. 31, 2023 5,000,000 994,965,427          
Balance at Jun. 30, 2023 $ 500 $ 86,891 123,554,174 390,024 (56,250) (170,236,548) (46,261,209)
Balance, shares at Jun. 30, 2023 5,000,000 868,263,739          
Issuance of common shares under financing agreement $ 3,181 563,089 (109,911) 456,359
Issuance of common shares under financing agreement, shares   31,808,246          
Dividends payable on Preferred Shares (59,616) (59,616)
Net income (loss) (2,646,539) (2,646,539)
Accretion of Series E Preferred Shares (9,300) (9,300)
Balance at Sep. 30, 2023 $ 500 $ 90,072 124,117,263 390,024 (166,161) (172,952,003) (48,520,305)
Balance, shares at Sep. 30, 2023 5,000,000 900,071,985          
Issuance of common shares under financing agreement $ 4,483 454,025 109,911 568,419
Issuance of common shares under financing agreement, shares   44,843,442          
Dividends payable on Preferred Shares (59,616) (59,616)
Common stock issued to consultants $ 4,000 596,000 600,000
Common stock issued to consultants, shares   40,000,000          
Net income (loss) (5,402,064) (5,402,064)
Accretion of Series E Preferred Shares (9,300) (9,300)
Shares issued upon exchange of Partitioned Note $ 1,000 159,000 160,000
Shares issued upon exchange of Partitioned Note, shares   10,000,000          
Common stock issued to employee $ 5 1,095 1,100
Common stock issued to employee, shares   50,000          
Accretion on Series G Preferred shares           (3,000) (3,000)
Balance at Dec. 31, 2023 $ 500 $ 99,560 $ 125,327,383 $ 390,024 $ (56,250) $ (178,425,983) $ (52,664,766)
Balance, shares at Dec. 31, 2023 5,000,000 994,965,427